The healthcare industry has long struggled with the fact that it is data rich but insights poor. Dozens of systems and platforms collect information on patients and populations at any given time during their care journey, yet extracting value from the sea of resulting data to improve outcomes and […]
Take Rebates and Accruals from Administrative Burden to Competitive Advantage
For many medtech manufacturers, bringing automation to rebate management is viewed as an operational efficiency gain. While there are certainly operational benefits to moving away from manual calculations, one-off customer communications, and cumbersome workflows, it’s also important for […]
Technology is changing how we practice medicine.
Sensors and wearables are getting smaller and cheaper, and algorithms are becoming powerful enough to predict medical outcomes. Yet despite rapid advances, healthcare lags behind other industries in truly putting these technologies to use. Driving meaningful patient outcomes with digital […]
Assuring Data Integrity in the Life Science Industry
Data integrity issues affect pharmaceutical companies everywhere. The majority of cases are caused by inefficient and fragmented business processes rather than deliberate fraud, most are captured by internal inspection and audit processes within the business and, therefore, remain buried and never […]
Unlocking the power of data to bring research to all
The data revolution is here. Researchers need real-world data to help them find answers to today’s most pressing healthcare questions. The ecosystem is ripe for disruption. Several key drivers across the industry are serving as change catalysts. To lead the way, Cerner has created an ecosystem of […]
Bridging the Cell and Gene Therapy Gap Between Manufacture and the Supply Chain
Cell, gene-modified cell and gene therapies hold the promise to offer new hope and novel therapeutic avenues for individuals facing serious illnesses and medical conditions. But bringing these therapies successfully through the clinical trial process introduces a level of supply chain risk, […]
The Role of Real-World Evidence in FDA Approvals
Aetion’s comprehensive eBook—updated for 2021 with new data and case studies—is designed to help inform your RWE strategy, guiding you through when, where, and how RWE studies have supported FDA decisions.You’ll also learn: How often RWE studies provided substantial or supportive evidence […]
Real-Time Benefit Tools: Are You Ready for the Reform?
When out-of-pocket costs rise, Medicare beneficiaries are more likely to ration or stop taking medications as prescribed. Likewise, increased patient cost-sharing can lead to decreased adherence and lower health outcomes. Upcoming CMS mandates aim to give consumers increased drug price […]
Back to consumer: Novartis’ digital chief Betrand Bodson is leaving pharma after helping break ground
Accurate Patient Matching: Why It’s Critical to Get It Right
The “Ins” and “Outs” of Revenue Cycle Management: Income by Outsourcing
Specificity is the New Black: A Guide to Getting Greater Reimbursement
3 Steps for Building your SDOH Business Case
Scale Your Virtual Care Strategy to Rising-Risk Populations with Deviceless Remote Patient Monitoring
Maximize Your Value-Based Care Bottom Line
Getting the Rising Risk Patient Population Under Control
Star Ratings have been changing since their inception and likely will continue to do so while they remain in force.
Unlocking the Potential of Digital Value-Based Care Solutions
Digital Health Trends 2021
Innovation in digital health tools, including mobile health apps and wearable sensors, bring new approaches to the management of health conditions. Digital therapeutics to treat human disease are being approved by regulatory agencies around the world and routes to reimbursement are being established […]
How Health-Related Social Media Can Complement Traditional Real-World Evidence Approaches to Offer Unique Patient Insights
Traditional real-world evidence (RWE) is based on data collected in normal clinical practice outside of randomized controlled trials. It is used to complement clinical data in regulatory and health technology assessment submissions. This data is most often generated through retrospective or […]
What You Need to Know About Real-World Databases in Japan
Valuable information for real-world evidence generation can be gleaned from healthcare databases, and the number of databases available continues to expand. Knowing the right data to answer the right question is critical in effective study design. While much is known about use and access of data […]
Managing Diabetic Health Outcomes Remotely
Changing healthcare landscapes allow healthcare providers and their patients more options for care than ever before. Integrating virtual care options into the long-term care of diabetic patients can have a significant and measurable impact on both clinical and financial outcomes within this […]
Artificial Intelligence (AI) in Medical Diagnostics Market by Component (Software, Service), Application (In Vivo, Radiology, OBGY,MRI, CT, Ultrasound, IVD), End User (Hospital, Diagnostic Laboratory, Diagnostic Imaging Center)- Global Forecast to 2025
Report Highlights: The global AI in medical diagnostics market is projected to reach USD 3,868 million by 2025 from USD 505 million in 2020, at a CAGR of 50.2% during the forecast period. Growth in this market is primarily driven by government initiatives to increase the adoption of AI-based […]
Learn the fundamentals of Real World Evidence in Oncology Drug Development
Uses of real world data have played a role in every stage of clinical development from pre-clinical assessment of unmet need, to comparative effectiveness analysis for market access. Challenges commonly faced by clinical development in oncology make methods involving real world evidence prized […]
The Use of Medicines in the U.S.
Spending and Usage Trends and Outlook to 2025 According to a new report from the IQVIA Institute for Human Data Science – The Use of Medicines in the U.S. – the U.S. health system demonstrated resilience and flexibility during 2020, recovering toward its pre-pandemic levels of activity and […]
Advanced HCP Targeting
Precise HCP targeting is critical to maximizing your sales force and marketing activity investment. Explore IQVIA’s holistic HCP targeting solution, purpose-built to address today’s evolving market. Download the Insight Brief and learn how to: Create a true market opportunity assessment […]
10 Critical Questions to Ask When Evaluating a PE Analysis
In this free White Paper, we are going to walk step-by-step through: The ONE type of pharmacoeconomic analysis you cannot do without when evaluating new drugs This type of analysis lets you directly compare all of the costs and health benefits of drugs used to treat different disease states, […]
Market access for regenerative medicines and rare disease therapies
Market access strategies for regenerative medicines, and rare and orphan disease treatments are particularly complex. This collection of case studies illustrates some of the challenges and opportunities for manufacturers, including: mapping the policy landscape and understand evolving payer […]
What is Data Fabric Design?
Explore Data Fabric Design “Every data and analytics leader’s goal is to reach decisions, actions, and output faster. Automation is inevitable to achieve this. In a recent Gartner survey, 50% of data and analytics leaders want to entirely automate data integration, a third want to automate data […]
International Profiles of Health Care Systems
How are healthcare systems around the world organised? This very useful resource provides concise profiles of healthcare systems in 20 countries. Key topics covered include: How universal health coverage works How the delivery system is organised and providers are paid Strategies to […]
